Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) Research & Development (2016 - 2025)

Aspen Aerogels' Research & Development history spans 13 years, with the latest figure at $2.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 36.55% year-over-year to $2.8 million, compared with a TTM value of $13.4 million through Dec 2025, down 25.67%, and an annual FY2025 reading of $13.4 million, down 25.67% over the prior year.
  • Research & Development for Q4 2025 was $2.8 million at Aspen Aerogels, up from $2.5 million in the prior quarter.
  • The five-year high for Research & Development was $4.7 million in Q3 2022, with the low at $2.4 million in Q1 2021.
  • Average Research & Development over 5 years is $3.8 million, with a median of $4.1 million recorded in 2023.
  • Year-over-year, Research & Development surged 70.45% in 2022 and then crashed 45.68% in 2025.
  • Tracing ASPN's Research & Development over 5 years: stood at $3.3 million in 2021, then increased by 26.68% to $4.2 million in 2022, then dropped by 2.91% to $4.1 million in 2023, then increased by 8.1% to $4.4 million in 2024, then plummeted by 36.55% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's Research & Development are $2.8 million (Q4 2025), $2.5 million (Q3 2025), and $3.8 million (Q2 2025).